Macrophages and cancer: from mechanisms to therapeutic implications

Trends in Immunology
Renato OstuniGioacchino Natoli

Abstract

Infiltration by immune cells is a hallmark of most forms of malignancy. In this context, tumor-associated macrophages (TAMs) represent key regulators of the complex interplay between the immune system and cancer. We discuss evidence indicating that in many settings TAMs fuel, rather than limit, tumor progression, and negatively impact on responses to therapy. We discuss how the unique functional properties of TAMs are shaped by tumor-derived signals, placing TAM development in the context of the broader understanding of the cellular and molecular mechanisms controlling macrophage origin, differentiation, and maintenance in tissues. Finally, we provide examples of how a molecular understanding of the relationships between TAMs and the tumor microenvironment may lead to improved cancer therapies.

References

Jan 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Lorne J HofsethCurtis C Harris
Mar 30, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Ross SummerAlan Fine
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Robert B WestMatt van de Rijn
Nov 23, 2006·Cancer Research·Elaine Y LinJeffrey W Pollard
Dec 25, 2008·Annual Review of Immunology·Fernando O MartinezSiamon Gordon
Feb 17, 2009·The American Journal of Pathology·Laureen S OjalvoJeffrey W Pollard
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Feb 9, 2010·Cancer Cell·Pauline AndreuLisa M Coussens
Mar 12, 2010·The New England Journal of Medicine·Christian SteidlRandy D Gascoyne
Mar 23, 2010·Cell·Sergei I GrivennikovMichael Karin
Apr 8, 2010·Cell·Bin-Zhi Qian, Jeffrey W Pollard
Aug 13, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Krithika N KodumudiJulie Y Djeu
Sep 22, 2010·Nature Immunology·Subhra K Biswas, Alberto Mantovani
Feb 23, 2011·The Journal of Experimental Medicine·Alexander Pedroza-GonzalezA Karolina Palucka
Mar 3, 2011·Nature Reviews. Clinical Oncology·Laurence ZitvogelGuido Kroemer
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Aug 2, 2011·Nature Immunology·Maria T PallottaUrsula Grohmann
Aug 10, 2011·Proceedings of the National Academy of Sciences of the United States of America·Brian RuffellLisa M Coussens
Sep 14, 2011·The Journal of Clinical Investigation·Tangying LuDmitry Gabrilovich
Sep 21, 2011·The Journal of Experimental Medicine·Barbara MolonAntonella Viola
Oct 15, 2011·Nature Reviews. Immunology·Peter J Murray, Thomas A Wynn
Oct 26, 2011·Nature Reviews. Immunology·Toby Lawrence, Gioacchino Natoli
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Virna Cortez-RetamozoMikael J Pittet
Mar 23, 2012·Nature Reviews. Immunology·Dmitry I GabrilovichVincenzo Bronte
Nov 20, 2012·Annual Review of Immunology·Guido KroemerLaurence Zitvogel

❮ Previous
Next ❯

Citations

Nov 26, 2015·Nature Reviews. Clinical Oncology·Mark J SmythMichele W L Teng
Jun 26, 2015·Membranes·Jonas Heilskov Graversen, Søren Kragh Moestrup
Feb 18, 2016·Journal for Immunotherapy of Cancer·Edward C StackPeter P Lee
Feb 5, 2016·Cancer Letters·Ting Wu, Yun Dai
Mar 8, 2016·Trends in Cancer·Ruth A Franklin, Ming O Li
Jul 27, 2015·Current Opinion in Cell Biology·Aparna RatheeshDaria E Siekhaus
Oct 2, 2015·Current Opinion in Pharmacology·Joachim L Schultze
Dec 29, 2015·Cancer Letters·Aida HabtezionStephen J Pandol
Dec 22, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yihua Pei, Yoon Yeo
Sep 18, 2015·American Journal of Respiratory Cell and Molecular Biology·Yoshito TakedaIsao Tachibana
Mar 18, 2016·Immunity·Thomas A Wynn, Kevin M Vannella
May 4, 2016·Oncoimmunology·Gerhard HamiltonMaximilan J Hochmair
Jul 27, 2015·Cellular and Molecular Life Sciences : CMLS·Antonio SicaChiara Porta
Aug 26, 2015·Seminars in Immunology·Joachim L SchultzeS Goerdt
Sep 29, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ling WangBao-En Shan
Aug 1, 2015·Human Gene Therapy·Gunilla EnbladAngelica S I Loskog
Jul 8, 2015·Journal of Cancer Prevention·Yoon Jung YangJin Woo Choi
May 26, 2016·Breast Cancer Research : BCR·Maria Peiris-PagèsMichael P Lisanti
Jul 6, 2016·Current Opinion in Virology·Amanda Rosewell Shaw, Masataka Suzuki
Aug 3, 2016·The Journal of Clinical Investigation·Dana M HardbowerKeith T Wilson
Apr 29, 2016·BJU International·Jennifer M Mataraza, Philip Gotwals
Oct 28, 2016·Molecular Carcinogenesis·Mark SpawSufi Mary Thomas
Dec 10, 2016·Expert Opinion on Investigational Drugs·Bryan OronskyCorey A Carter
Nov 20, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Micol RavàBruno Amati
Jan 23, 2017·Cancer Letters·Shuai Jiang, Wei Yan
Dec 14, 2016·Annual Review of Physiology·Kevin M Vannella, Thomas A Wynn
Mar 14, 2017·Laboratory Investigation; a Journal of Technical Methods and Pathology·Anna GieryngBozena Kaminska
Mar 9, 2017·Genes & Development·Liv Austenaa, Gioacchino Natoli
Apr 7, 2017·Journal of the National Cancer Institute·Stefan B EichmüllerBarbara Seliger
Mar 22, 2016·NPJ Breast Cancer·Carly Bess WilliamsAdam C Soloff
Nov 30, 2016·Veterinary Research·Nitish BoodhooShahriar Behboudi
Jan 18, 2017·Proceedings of the National Academy of Sciences of the United States of America·Dana M HardbowerKeith T Wilson
Jan 21, 2017·Journal of Cellular Biochemistry·Muhammad TariqBo Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.